专利检索 ap:("EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY") AND inv:"Qiannan LI" 第 1 页

1.

发明申请
QUINAZOLINE COMPOUND SERVING AS EGFR TRIPLE MUTATION INHIBITOR AND APPLICATIONS THEREOF 有权

公开(公告)号：US20210155604A1

公开(公告)日：2021-05-27

申请号：US17047002

申请日：2019-04-12

申请人： EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY

发明人： Honglin LI , Jian DING , Yufang XU , Hua XIE , Qiannan LI , Tao ZHANG , Zhenjiang ZHAO

IPC分类号： C07D401/14 , C07D401/12 , C07F9/6558 , C07D239/94 , C07D403/12

摘要： Related to a quinazoline compound serving as an EFGR triple mutation inhibitor and applications thereof. Specifically, disclosed are a compound as represented by the following formula (I), a pharmaceutical composition comprising the compound of formula (I), and applications of the compound in treating a related disease mediated by EGFR and in a medicament for treating the related disease mediated by EGFR.